Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
The Customer Service Intermediate Analyst is an intermediate-level position responsible for providing clients with resolutions and support in coordination with the Customer Service team. The overall objective of this role is to address external customer issues
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives
Location: You will primarily work in the Chiba area. Your residence is expected to be in Chiba or Tokyo. Are you ready to make a meaningful impact in the pharmaceutical industry? At Regeneron, we’re committed to
At EY, we’re all in to shape your future with confidence. We’ll help you succeed in a globally connected powerhouse of diverse teams and take your career wherever you want it to go. Join EY and
Do you enjoy leading a team that provides a high-quality of service to customers? Are you a Project Management Leader looking for a new opportunity? Join our Baker Hughes Valves Team! We devise smarter systems to
At EY, you’ll have the chance to build a career as unique as you are, with the global scale, support, inclusive culture and technology to become the best version of you. And we’re counting on your
Job Description: Business Overview Rakuten Group provides more than 70 services in a wide range of fields, including e-commerce, travel, digital content, and other Internet services in Japan and overseas, as well as financial services such
Discover your future at Citi / シティでキャリアを築く Working at Citi is far more than just a job. A career with us means joining a team of more than 230,000 dedicated people from around the globe. At
Discover your future at Citi / シティでキャリアを築く Working at Citi is far more than just a job. A career with us means joining a team of more than 230,000 dedicated people from around the globe. At
Job Description: Department Overview Rakuten Travel’s global business is expanding travel-related services for overseas markets, partners, and customers. Rakuten Travel Xchange Business Office and Global Travel Management Department work with business, marketing, product, customer support, administrative
At EY, we’re all in to shape your future with confidence. We’ll help you succeed in a globally connected powerhouse of diverse teams and take your career wherever you want it to go. Join EY and
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Job Description: Department Overview The Global Travel Management Department of Rakuten Travel is accelerating Rakuten Travels global business expansion, particularly services for international users traveling to Japan and future global business development. Through travel services centered
Company Description At Western Digital, our vision is to power global innovation and push the boundaries of technology to make what you thought was once impossible, possible. At our core, Western Digital is a company of
At EY, you’ll have the chance to build a career as unique as you are, with the global scale, support, inclusive culture and technology to become the best version of you. And we’re counting on your
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)